MJNA Stock Overview
An investment holding company, operates in the cannabinoid-based nutraceutical industry. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Medical Marijuana, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0005 |
| 52 Week High | US$0.0043 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 1 Month Change | -9.09% |
| 3 Month Change | -50.00% |
| 1 Year Change | -86.11% |
| 3 Year Change | -97.58% |
| 5 Year Change | -97.78% |
| Change since IPO | -99.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| MJNA | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 66.7% | -1.5% | -2.8% |
| 1Y | -86.1% | -12.9% | 24.1% |
Return vs Industry: MJNA underperformed the US Healthcare industry which returned -12.9% over the past year.
Return vs Market: MJNA underperformed the US Market which returned 24.1% over the past year.
Price Volatility
| MJNA volatility | |
|---|---|
| MJNA Average Weekly Movement | 29.3% |
| Healthcare Industry Average Movement | 7.6% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 18.0% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: MJNA's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: MJNA's weekly volatility (29%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | n/a | Timothy Scott | www.medicalmarijuanainc.com |
Medical Marijuana, Inc., an investment holding company, operates in the cannabinoid-based nutraceutical industry. It focuses on the development, sale, and distribution of hemp oil that contains naturally occurring cannabinoids, including cannabidiol (CBD) and other products containing CBD-rich hemp oil; treatment of pain and other medical disorders with the application of chewing gum-based cannabis/cannabinoid medical products; and nonpsychoactive cannabidiol products. The company is also involved in the research and development of new therapeutic agents that are designed to reduce oxidative stress and act as immuno-modulators and neuroprotectants; dietary supplements, skin care products, and prescription-based hemp oil under the Kannaway and HempMeds brands; and proprietary testing, genetics, labeling and packaging, tracking, and production and standardization methods for the medicinal cannabinoid industry.
Medical Marijuana, Inc. Fundamentals Summary
| MJNA fundamental statistics | |
|---|---|
| Market cap | US$2.92m |
| Earnings (TTM) | US$8.80m |
| Revenue (TTM) | US$58.98m |
0.0x
P/E Ratio0.0x
P/S RatioIs MJNA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MJNA income statement (TTM) | |
|---|---|
| Revenue | US$58.98m |
| Cost of Revenue | US$12.50m |
| Gross Profit | US$46.48m |
| Other Expenses | US$37.69m |
| Earnings | US$8.80m |
Last Reported Earnings
Jun 30, 2020
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did MJNA perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/03 22:59 |
| End of Day Share Price | 2025/01/03 00:00 |
| Earnings | 2020/06/30 |
| Annual Earnings | 2019/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Medical Marijuana, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|